- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02775526
TOT, TVT And Burch Colpo-Suspension for Treatment of Female Mixed Urinary Incontinence
January 26, 2020 updated by: Mohamed S Sweed, MD, Ain Shams University
Trans-Obturator Tape, Tension-Free Vaginal Tape and Burch Colposuspension for Treatment of Female Mixed Urinary Incontinence: A Randomized Clinical Trial
This prospective interventional randomized controlled trial will recruit women with MUI scheduled for surgical treatment where patients will be randomized to either Burch colposuspension, TOT or TVT.
Regular postoperative follow up will be planned for at least 2 years.
The primary outcome measures will be the objective and subjective cure rates.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
220
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Ain Shams University Maternity Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women with mixed urinary incontinence.
Exclusion Criteria:
- Women with associated gynecological surgery e.g. uterine prolapse, previous anti-incontinence surgery, intrinsic sphincter deficiency (ISD), and medical disorders affecting the bladder innervation as diabetes mellitus were excluded from the study.
- Women who improved on medical treatment with persistence of stress element only were also excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: TOT
|
70 patients
Other Names:
|
|
Active Comparator: TVT
|
70 patients
Other Names:
|
|
Active Comparator: Burch colposuspension
|
70 patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
objective cure rate
Time Frame: 2 years
|
2 years
|
|
subjective cure rate
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
January 10, 2020
Study Completion (Actual)
January 10, 2020
Study Registration Dates
First Submitted
May 15, 2016
First Submitted That Met QC Criteria
May 16, 2016
First Posted (Estimate)
May 17, 2016
Study Record Updates
Last Update Posted (Actual)
January 28, 2020
Last Update Submitted That Met QC Criteria
January 26, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AS1234
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment
-
University of PadovaUniversity of Turin, ItalyNot yet recruiting
-
Psychiatric Centre RigshospitaletAstraZenecaTerminatedMedical Treatment | Antipsychotic Treatment | Quality AssuranceDenmark
-
Vilniaus Implantologijos Centro (VIC) KlinikaInstitut Straumann AGActive, not recruitingSingle Implant; Immediate Implant Treatment; Early Implant TreatmentLithuania
-
Sunnybrook Health Sciences CentreRecruitingTreatment-Resistant Depression | Treatment-resistant Depression (TRD)Canada
-
Chinese PLA General HospitalNot yet recruitingTreatment for Advanced Colorectal Cancer | Treatment for Advanced Pancreatic Cancer
-
Dr. Stavroula RakitziActive, not recruitingTreatment Resistant Schizophrenia | Treatment Resistant Bipolar DisorderGreece
-
NeuroRx, Inc.neurocare group AG; Zeta Surgical, Inc.; HOPE Therapeutics, Inc.Not yet recruitingTreatment Resistant Depression | Treatment Resistant Depression (TRD)United States
-
Ajman UniversityCompletedTreatmentUnited Arab Emirates
-
Nanjing University School of MedicineCompleted
-
Entheon Biomedical Corp.TerminatedTreatment-resistant DepressionUnited States
Clinical Trials on TOT
-
Klinikum der Universität KölnUnknown
-
Coordinación de Investigación en Salud, MexicoUnknownStress Urinary IncontinenceMexico
-
Izzet CelegenRecruitingStress Urinary Incontinence | Pelvic Floor Dysfunction | Female Urinary IncontinenceTurkey
-
Al-Azhar UniversityRecruitingStress Urinary IncontinenceEgypt
-
Hacettepe UniversityCompletedFatigue | Performance | Childhood Cancer | Functional IndependenceTurkey
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Alberta Health services; Boston... and other collaboratorsCompletedStress Urinary IncontinenceCanada
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
-
Royal Devon and Exeter NHS Foundation TrustCompletedPatient Education
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Al-Azhar UniversityRecruitingStress Urinary Incontinence | Burch ColposuspentionEgypt